Filtros de búsqueda

Lista de obras de

A Novel Predictive Model for In-Hospital Mortality Based on a Combination of Multiple Blood Variables in Patients with ST-Segment-Elevation Myocardial Infarction

artículo científico publicado en 2020

Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials.

artículo científico publicado en 2018

Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care

scientific article published on 02 September 2020

Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial

artículo científico publicado en 2019

Differential effect of concomitant antidiabetic agents on carotid atherosclerosis: a subgroup analysis of the PROLOGUE study

artículo científico publicado en 2018

Effect of pemafibrate, a novel selective peroxisome proliferator-activated receptor-alpha modulator (SPPARMα), on urinary protein excretion in IgA nephropathy with hypertriglyceridemia

artículo científico publicado en 2020

Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials

article

Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure.

artículo científico publicado en 2018

Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial

scientific article published on 22 April 2020

How should we monitor the cardiovascular benefit of sodium-glucose cotransporter 2 inhibition?

artículo científico publicado en 2020

Prognostic Impact of Serum Albumin for Developing Heart Failure Remotely after Acute Myocardial Infarction

artículo científico publicado en 2020

Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial

artículo científico publicado en 2020

Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelia

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda